Bunyaviridae nonstructural S proteins (NSs) are synthesized by viral DNA/RNA and do not play a role in the replication or the viral protein coating. [1] The nonstructural S segment (NSs) created by Bunyaviridae virus family, are able to interact with the human immune system, in order to increase their replication in infected cells. [2] Understanding this mechanism can have global health impacts. [3]
Within the Bunyaviridae virus family, specifically phlebovirus genus, there has been multiple pathways of the inhibition of the immune response. [3] NSs proteins are able to interact with interferon (INF) pathways, but the mechanism varies from virus to virus. [4] The NSs protein in different viruses have been shown to differ in amino acid sequence by up to 85%. [5]
NSs protein is distributed throughout the cytoplasm and nucleus of the RVFV-infected cell. The protein created fiber-like substances within the nucleus. [3] NSs in RVFV to the SAP30 region of DNA in the nucleus of the cell, which is an important promotor region of INF-b. [6] Many other NSs proteins in the Bunyaviridae virus family do not function in this same way. [5]
Although the exact target of the SFTSV is unknown, many believe that the virus attacks human hemopoietic cells. [7] It has been shown that upstream molecules of INFs are unchanged in infected cells, such as MAVS, TRAF6 and TRAF3. [7] This suggests that INFs are still being produced, but they have no effect and are undetectable in people's blood serum. [6] The NSs protein in SFTSV has been shown to interfere with TBK1 which is needed in the activation of both IRF and NF-κB pathways. [7]
UUKV is a non-human pathogen that still creates a NSs protein. [5] The NSs protein has only been shown to weakly interact with the 40s subunit of ribosomes and MAVS. [8] [9] [10]
AMTV is another non-human pathogen and its NSs protein is quickly degraded by proteasomes, and therefore doesn't cause infection in humans. [11]